INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 114 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $108,000 | -51.6% | 61,100 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $223,000 | -21.8% | 61,100 | +10.1% | 0.00% | 0.0% |
| Q4 2021 | $285,000 | -28.8% | 55,500 | +2.8% | 0.00% | 0.0% |
| Q3 2021 | $400,000 | -18.0% | 54,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $488,000 | +2.5% | 54,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $476,000 | -0.4% | 54,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $478,000 | -24.5% | 54,000 | -4.4% | 0.00% | -33.3% |
| Q3 2020 | $633,000 | +904.8% | 56,500 | +89.0% | 0.00% | – |
| Q3 2019 | $63,000 | -64.0% | 29,900 | -50.0% | 0.00% | -100.0% |
| Q2 2019 | $175,000 | -4.9% | 59,800 | +64.3% | 0.00% | 0.0% |
| Q1 2019 | $184,000 | +55.9% | 36,400 | +21.7% | 0.00% | 0.0% |
| Q4 2018 | $118,000 | -35.9% | 29,900 | -17.9% | 0.00% | 0.0% |
| Q3 2018 | $184,000 | +26.9% | 36,400 | -2.7% | 0.00% | 0.0% |
| Q2 2018 | $145,000 | -17.6% | 37,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $176,000 | -22.1% | 37,400 | -8.8% | 0.00% | -50.0% |
| Q4 2017 | $226,000 | 0.0% | 41,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $226,000 | -30.5% | 41,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $325,000 | +21.3% | 41,000 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $268,000 | -14.4% | 41,000 | -7.9% | 0.00% | -33.3% |
| Q4 2016 | $313,000 | -17.6% | 44,500 | +8.5% | 0.00% | -25.0% |
| Q3 2016 | $380,000 | -1.8% | 41,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $387,000 | +47.1% | 41,000 | +34.4% | 0.00% | +33.3% |
| Q1 2016 | $263,000 | +2.7% | 30,500 | -16.4% | 0.00% | 0.0% |
| Q4 2015 | $256,000 | +23.1% | 36,500 | +1.4% | 0.00% | 0.0% |
| Q3 2015 | $208,000 | -24.9% | 36,000 | +5.9% | 0.00% | 0.0% |
| Q2 2015 | $277,000 | +18.9% | 34,000 | +19.3% | 0.00% | 0.0% |
| Q1 2015 | $233,000 | – | 28,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |